High dose therapy for acute myelocytic leukemia treatment strategy: What is the choice?
- 1 March 1993
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 4, S59-S80
- https://doi.org/10.1093/annonc/4.suppl_1.s59
Abstract
N. C. Gorin, K. Dicke, B. Löwenberg; High dose therapy for acute myelocytic leukemia treatment strategy: What is the choice?, Annals of Oncology, Volume 4, IssKeywords
This publication has 53 references indexed in Scilit:
- Minimal residual disease in leukemia: Studies in an animal model for acute myelocytic leukemia (bnml)The International Journal of Cell Cloning, 1990
- Treatment of acute myelogenous leukemiaEuropean Journal of Cancer and Clinical Oncology, 1989
- Allogeneic Bone Marrow Transplantation after Hyperfractionated Total-Body Irradiation and Cyclophosphamide in Children with Acute LeukemiaNew England Journal of Medicine, 1987
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986
- Collection, manipulation and freezing of haemopoietic stem cellsClinics in Haematology, 1986
- Marrow Transplantation from Related Donors Other Than HLA-Identical SiblingsNew England Journal of Medicine, 1985
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983
- Treatment of Acute Myelogenous Leukemia in Children and AdultsNew England Journal of Medicine, 1980
- Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First RemissionNew England Journal of Medicine, 1979
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979